Check out our most popular compounded medications! Get Started
Bayview Pharmacy's Estradiol 5 Mcg/Dehydroepiandrosterone 3 mg Vaginal Suppository is a specially compounded medication. It is a solid dosage form that is inserted into the vagina, where it dissolves to release the medication. This treatment is primarily used for conditions such as Vulvovaginal Atrophy, Menopause, Postmenopausal Osteoporosis, Urogenital Atrophy, and Dyspareunia.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy is pleased to provide a compounded formulation of Estradiol 5 Mcg/Dehydroepiandrosterone 3 mg in the form of a vaginal suppository. This solid dosage form is designed to be inserted into the vagina, where it dissolves or melts to release the medication. It is primarily used for the treatment of conditions such as vulvovaginal atrophy, menopause, postmenopausal osteoporosis, uterine fibroids, and hypoestrogenism.
The symptoms associated with these conditions, including vaginal dryness, hot flashes, and bone loss, can be significantly reduced with the use of this formulation. The combination of estradiol and dehydroepiandrosterone in this suppository works to restore the body's natural hormone balance, which can alleviate the symptoms of these conditions.
If you have any questions about this compounded formulation of Estradiol 5 Mcg/Dehydroepiandrosterone 3 mg vaginal suppository or would like to learn more about how it can help treat your condition, please do not hesitate to contact us. Our team is dedicated to helping you find the best treatment option tailored to your individual needs.
Estradiol 5 mcg/Dehydroepiandrosterone 3 mg Vaginal Suppository is a compounded formulation designed for the treatment of various conditions related to hormonal imbalances in women. These conditions include vulvovaginal atrophy, menopause, postmenopausal osteoporosis, uterine fibroids, and hypoestrogenism. The formulation contains two key active ingredients: Estradiol and Dehydroepiandrosterone (DHEA).
Estradiol is a form of estrogen, a female hormone primarily produced by the ovaries. It plays a crucial role in managing symptoms associated with menopause, such as hot flashes and vaginal dryness. Estradiol also contributes to the overall health of the female reproductive system and helps maintain bone density, thereby reducing the risk of osteoporosis.
Dehydroepiandrosterone (DHEA) is a hormone produced by the adrenal glands. It also aids in alleviating menopausal symptoms like hot flashes and night sweats. Additionally, DHEA has been found to help reduce the risk of osteoporosis and uterine fibroids, further enhancing its therapeutic value in this formulation.
The combination of estradiol and DHEA in this vaginal suppository provides a comprehensive approach to managing the symptoms of vulvovaginal atrophy, menopause, postmenopausal osteoporosis, uterine fibroids, and hypoestrogenism. This formulation is designed to dissolve or melt once inserted into the vagina, allowing for local or systemic absorption of the medication.
It is important to note that this formulation should not be used by women who are pregnant or breastfeeding due to potential risks. Always consult with a healthcare provider before starting any new medication regimen. If you have any questions or concerns about this formulation, please consult with your healthcare provider or pharmacist.
Estradiol 5 mcg/Dehydroepiandrosterone 3 mg Vaginal Suppository is a specially compounded medication designed to address a range of conditions associated with menopause, postmenopausal osteoporosis, uterine fibroids, hypoestrogenism, and vulvovaginal atrophy. The formulation contains two active ingredients: estradiol and dehydroepiandrosterone.
Estradiol, a form of estrogen, works to alleviate menopausal symptoms such as hot flashes and night sweats. Dehydroepiandrosterone, on the other hand, is a hormone that helps to mitigate the symptoms of postmenopausal osteoporosis, including bone loss and fractures.
The combination of these two hormones in this formulation also aids in reducing the symptoms of uterine fibroids, which can include heavy menstrual bleeding and pelvic pain.
Lastly, the Estradiol 5 mcg/Dehydroepiandrosterone 3 mg Vaginal Suppository is beneficial in managing symptoms of vulvovaginal atrophy, which can include vaginal dryness, itching, and burning. This medication is typically administered vaginally, usually once daily.
If you have any questions or concerns about this formulation, please do not hesitate to reach out for further information.
This compounded formulation of Estradiol 5 Mcg/Dehydroepiandrosterone 3 mg Vaginal Suppository is a solid dosage form designed for insertion into the vagina. Upon insertion, it dissolves or melts, releasing the medication for local or systemic absorption. This formulation is primarily used to treat a variety of conditions. It can be used to manage hypoactive sexual desire disorder (HSDD) in postmenopausal women, a condition characterized by a decrease in sexual desire. It can also be used to treat androgen deficiency in women, a hormonal imbalance that can lead to a variety of symptoms including fatigue, weight gain, and mood changes.
In addition to these uses, this formulation can also be used to manage premenstrual dysphoric disorder (PMDD), a severe form of premenstrual syndrome that can cause significant physical and psychological distress. Furthermore, it can be used to reduce the risk of endometrial hyperplasia, a condition characterized by the thickening of the lining of the uterus, in postmenopausal women with an intact uterus who are receiving estrogen therapy.
Lastly, this formulation can also be used to reduce the risk of recurrent urinary tract infections in postmenopausal women. Urinary tract infections are common in postmenopausal women due to changes in the urinary tract and a decrease in estrogen levels. If you have any questions about the use of this formulation for any of these conditions, please do not hesitate to reach out for further information.
This is a compounded medication that combines Estradiol and Dehydroepiandrosterone (DHEA) in a solid dosage form. It is designed to be inserted into the vagina, where it dissolves or melts to release the medication for local or systemic absorption.
This medication is typically used to treat symptoms of menopause such as vaginal dryness, burning, and irritation. It can also be used in the treatment of certain other conditions as determined by your healthcare provider.
You should insert this suppository into the vagina as directed by your healthcare provider. The medication will dissolve or melt, releasing the active ingredients for absorption.
If you miss a dose, use it as soon as you remember. If it is near the time of the next dose, skip the missed dose. Use your next dose at the regular time. Do not double the dose to catch up.
Common side effects may include vaginal discomfort or irritation, and increased vaginal discharge. If any of these effects persist or worsen, tell your doctor or pharmacist promptly.
This medication should not be used during pregnancy or while breastfeeding unless the benefits outweigh the risks. Always consult your healthcare provider before starting any new medication.
Before using this medication, tell your doctor or pharmacist of all the products you use, including any other vaginal products. They can provide guidance on whether these can be used concurrently.
Store this medication at room temperature, away from light and moisture. Do not store in the bathroom. Keep all medications away from children and pets.
If someone has overdosed and has serious symptoms such as passing out or trouble breathing, call emergency services immediately. Otherwise, call a poison control center right away.
It's best to consult your healthcare provider about this, as the effects of alcohol can vary depending on the individual and the specific medication.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Insert 1 unwrapped suppository
